Domestic pharmaceutical industry likely to gain steam in 2005

Korean pharmaceutical industry is expected gain momentum next year due to favorable business performance of major pharmaceutical firms, less regulatory pressure and visible outcome of R&D new drug projects, said a local analyst in a report.

In the first January-October period, the Korea Composite Stock Price rose 7.0 percent, while the pharmaceutical stock index climbed by 26.2 percent for t...